{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:01:59Z","timestamp":1784775719572,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.rmed.2025.108293","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T11:56:59Z","timestamp":1754395019000},"page":"108293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometasone furoate dry powder inhaler in Indian asthma patients"],"prefix":"10.1016","volume":"247","author":[{"given":"Chintan","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishal","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Koppula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avadhesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit S.","family":"Bhate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diptikant","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish Kumar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asish","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deven","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevinkumar","family":"Kansagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardik","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rmed.2025.108293_bib2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1183\/23120541.00528-2021","article-title":"Prevalence, time trends and treatment practices of asthma in India: the global asthma network study","volume":"8","author":"Singh","year":"2022","journal-title":"ERJ Open Res."},{"issue":"1","key":"10.1016\/j.rmed.2025.108293_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5334\/aogh.2416","article-title":"Pediatric asthma: a global epidemic","volume":"85","author":"Serebrisky","year":"2019","journal-title":"Ann. Glob. Health"},{"issue":"10210","key":"10.1016\/j.rmed.2025.108293_bib5","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0140-6736(19)32216-0","article-title":"Triple therapy in a single inhaler: a new option for uncontrolled asthma","volume":"394","author":"FitzGerald","year":"2019","journal-title":"Lancet."},{"issue":"13","key":"10.1016\/j.rmed.2025.108293_bib6","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.rmed.2025.108293_bib7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/14740338.2016.1199682","article-title":"Tiotropium for the treatment of asthma: a drug safety evaluation","volume":"15","author":"Kerstjens","year":"2016","journal-title":"Expet Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.rmed.2025.108293_bib8","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bph.14909","article-title":"Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: synergy of triple combination therapy on human airway smooth muscle ex vivo","volume":"177","author":"Rogliani","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.rmed.2025.108293_bib9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S2213-2600(20)30190-9","article-title":"Once-daily, single-inhaler mometasone-indacaterol- glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone- salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study","volume":"8","author":"Kerstjens","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108293_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40265-021-01518-w","article-title":"Indacaterol\/glycopyrronium\/mometasone: a review in asthma","volume":"81","author":"Blair","year":"2021","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.rmed.2025.108293_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40265-015-0354-5","article-title":"Fluticasone furoate\/vilanterol: a review of its use in patients with asthma","volume":"75","author":"Syed","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.rmed.2025.108293_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12931-020-01407-y","article-title":"Tiotropium in chronic obstructive pulmonary disease \u2013 a review of clinical development","volume":"21","author":"Anzueto","year":"2020","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.rmed.2025.108293_bib13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/all.15076","article-title":"Single inhaler triple therapy (SITT) in asthma: systematic review and practice implications","volume":"77","author":"Agusti","year":"2022","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.rmed.2025.108293_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/17476348.2021.2011222","article-title":"Indacaterol\/glycopyrronium\/mometasone fixed dose combination for uncontrolled asthma","volume":"16","author":"Pelaia","year":"2022","journal-title":"Expert Rev. Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108293_bib15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/TCRM.S1984","article-title":"Fluticasone furoate nasal spray in the treatment of allergic rhinitis","volume":"4","author":"Giavina-Bianchi","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"issue":"1","key":"10.1016\/j.rmed.2025.108293_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1465-9921-8-54","article-title":"Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate","volume":"8","author":"Valotis","year":"2007","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.rmed.2025.108293_bib17","doi-asserted-by":"crossref","first-page":"L660","DOI":"10.1152\/ajplung.00108.2007","article-title":"Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease","volume":"293","author":"Salter","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108293_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.112.198481","article-title":"In vitro pharmacological characterization of vilanterol, a novel long-acting beta2-adrenoceptor agonist with 24-hour duration of action","volume":"344","author":"Slack","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.rmed.2025.108293_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12890-024-03190-8","article-title":"Comparison of budesonide\/formoterol versus fluticasone furoate\/vilanterol as maintenance and reliever therapy for asthma control: a real-world observational study","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Pulm. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108293_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125003567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125003567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:52:53Z","timestamp":1767714773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125003567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":18,"alternative-id":["S0954611125003567"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108293","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometasone furoate dry powder inhaler in Indian asthma patients","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108293"}}